Trial ID | Maryland Oncology Hematology Trial ID – Maryland Oncology Hematology

Trial ID

Trial Information - Phase III

A PHASE 3, OPEN-LABEL, 3-COHORTRANDOMIZED STUDY OF N-803 IN COMBINATIONWITH CURRENT STANDARD OF CARE VS STANDARDOF CARE AS FIRST-LINE TREATMENT FORPATIENTS WITH ADVANCED OR METASTATICNON-SMALL CELL LUNG CANCER

Disease Specifics: NSCLC

Protocol ID: QUILT-2.023

Sponsor: Immunity Bio

Status: STUDY ON HOLD

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Lung

Investigator

Narang MD, Mohit

Status

STUDY ON HOLD

Sponsor

Immunity Bio

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology